Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naringin Tablets for Postinfectious Cough (Phase II, Randomized, Double-blind, Placebo-controlled, Multicenter)
CTR20260614Phase 2Active
- Sponsor
- Sun Yat-sen University
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naringin in postinfectious cough, sponsored by Sun Yat-sen University. Started May 2026; status: active.
02
Drugs
naringin
03
Conditions
postinfectious cough
Beyond the preview
Go deeper on CTR20260614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260614.